A Canadian-led study has identified genes which may be partially responsible for the development of cerebral palsy.
Catalyst licenses Santhera Pharmaceuticals’ vamorolone
Vamorolone has received orphan drug status in the US to treat Duchenne muscular dystrophy. Credit: StudioMolekuul / shutterstock.com. Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed